Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
(feeds.nature.com)
61.
62.
Stop Treating Water as a Utility Bill. It’s Your Hidden Energy Trade
(feeds.feedburner.com)
63.
FDA Turns to AI to Speed Up Clinical Trials
(feeds.content.dowjones.io)
64.
Trial Begins Between Elon Musk and Sam Altman for the Future of OpenAI
(feeds.content.dowjones.io)
65.
66.
67.
68.
69.
70.
Getting my daily news from a dot matrix printer 2024
(news.ycombinator.com)
71.
The rise of days-long (and often unpaid) ‘work trials’ for job applicants
(feeds.feedburner.com)
72.
A Push to Digitize the Forest
(feeds.content.dowjones.io)
73.
Redwood Materials loses COO amid layoffs, restructuring
(techcrunch.com)
74.
Carbon nanotube wiring gets closer to competing with copper
(arstechnica.com)
75.
76.
The Hunt for Extraterrestrial Life Enters a New Frontier
(feeds.content.dowjones.io)
77.
Our newsroom AI policy
(news.ycombinator.com)
78.
Ars Technica: Our newsroom AI policy
(news.ycombinator.com)
79.
We need to talk about failure in science
(feeds.nature.com)
80.
Our newsroom AI policy
(arstechnica.com)
81.
82.
83.
84.
85.
86.
A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin
(feeds.nature.com)
87.
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer
(feeds.nature.com)
88.
89.
Waiting for them
(feeds.nature.com)
90.
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease
(feeds.content.dowjones.io)